PharmAla Biotech Holdings Inc. have received an export permit for 300 grams of its LaNeo MDMA. PharmAla believes this is the largest single Health Canada export permit ever granted by weight to date. The MDMA is destined for a client in the United Kingdom; the materials will be used in research and development, for a proposed commercial purpose.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 CAD | 0.00% | -8.33% | -21.43% |
05-03 | PharmAla Up Near 8% As Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy | MT |
04-23 | Red Light Holland Corp. Initiates Psilocybin Extraction Phase with PharmAla | CI |
1st Jan change | Capi. | |
---|---|---|
-21.43% | 7M | |
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- MDMA Stock
- News Pharmala Biotech Holdings Inc.
- PharmAla Biotech granted an Export Permit for 300 grams of LaNeo™ MDMA